T Cell News and Research

Latest T Cell News and Research

Researcher receives $1.5M grant from NIH to find clues into causes of Alzheimer's

Alzheimer's is a progressive brain disease that affects older adults, slowly destroys their memories and may cause dementia. According to estimates from the National Institutes of Health (NIH), the disease may affect as many as 5.1 million Americans.

22 May 2014

Erlotinib, gefitinib have similar efficacy in NSCLC patients with EGFR mutation

Disease progression-free survival is similar for patients with non-small-cell lung cancer and epidermal growth factor receptor mutations whether they receive erlotinib or gefitinib, show the results of a South Korean study.

21 May 2014

Bendamustine modestly efficacious but well tolerated in SCLC

Patients with relapsed or treatment-resistant small-cell lung cancer can achieve modest survival benefits with few side effects when treated with bendamustine, report US researchers.

21 May 2014

Cholesterol plays vital role in cell mobility and tissue invasion

University of Barcelona's researchers led by Professor Carles Enrich, from the Department of Cell Biology, Immunology and Neurosciences of the Faculty of Medicine at the University of Barcelona and CELLEX Biomedical Research Centre of IDIBAPS, have found that cholesterol plays a key role in cell mobility and tissue invasion.

21 May 2014

New laser method provides a better understanding on how genes are controlled, regulated

Almost every one of our cells has an entire copy of our genome. But only differing subsets of genes are active and expressed in any given cell.

21 May 2014

Researchers explore hair cells of inner ear to reverse hearing loss

The ability to discern pitch - to hear the difference between "cat," "bat" and "hat," for example - hinges on remarkable gradations in specialized cells within the inner ear.

21 May 2014

Mayo Clinic study provides key insights into aggressive form of pancreatic cancer

Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

21 May 2014

Combination of metformin and rapamycin shows potential in treating aging and related diseases

A proven approach to slow the aging process is dietary restriction, but new research in the Linus Pauling Institute at Oregon State University helps explain the action of a drug that appears to mimic that process - rapamycin.

21 May 2014

New in vitro 12-cell line panel assay predicts anti-cancer drug activity

Southern Research Institute today announced a new service offering - a novel in vitro 12-cell line panel assay designed to predict drug activity and improve the success rate of drugs tested in xenograft models.

21 May 2014

Cell Science Systems launches new blood test profile for GI disorders

Distinguishing the cause of gut disorders can be complicated. Therefore, Cell Science Systems, Corp. today announced the launch of a new test to help clinicians reach a diagnosis; and, suggest dietary strategies to improve whatever gut malady a person may have.

21 May 2014

New cancer drug candidates can be identified faster by using computer-assisted screening

A team of research scientists from VTT Technical Research Centre of Finland, the University of Turku and the University of Eastern Finland has discovered a previously unknown Cent-1 molecule that kills cancer cells.

21 May 2014

Supermodel mouse reveals critical role played by unknown gene that regulates metabolism

A lean "Supermodel" mouse type has revealed the potentially critical role played by a largely unknown gene that regulates metabolism, findings that could provide new insight into diseases ranging from diabetes to obesity, a new study by UT-Southwestern Medical Center researchers suggests.

21 May 2014

Research provides key insights into most aggressive form of pancreatic cancer

Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

21 May 2014

Substance from pine bark is a potential source for treating melanoma

A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

T Cell News and Research

Latest T Cell News and Research

Researcher receives $1.5M grant from NIH to find clues into causes of Alzheimer's

Erlotinib, gefitinib have similar efficacy in NSCLC patients with EGFR mutation

Bendamustine modestly efficacious but well tolerated in SCLC

Cholesterol plays vital role in cell mobility and tissue invasion

New laser method provides a better understanding on how genes are controlled, regulated

Researchers explore hair cells of inner ear to reverse hearing loss

Mayo Clinic study provides key insights into aggressive form of pancreatic cancer

Combination of metformin and rapamycin shows potential in treating aging and related diseases

New in vitro 12-cell line panel assay predicts anti-cancer drug activity

Cell Science Systems launches new blood test profile for GI disorders

New cancer drug candidates can be identified faster by using computer-assisted screening

Supermodel mouse reveals critical role played by unknown gene that regulates metabolism

Research provides key insights into most aggressive form of pancreatic cancer

Substance from pine bark is a potential source for treating melanoma

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

New LASER could revolutionize medicine and our knowledge of the human genome

Space Station science: Microgravity on human thyroid carcinoma cells

Pemetrexed plus erlotinib shows benefits in NSCLC

Three Chicago-area universities to share research facilities at reduced cost

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in